CellaVision AB (CEVI) - Total Assets

Latest as of December 2025: Skr1.09 Billion SEK ≈ $117.83 Million USD

Based on the latest financial reports, CellaVision AB (CEVI) holds total assets worth Skr1.09 Billion SEK (≈ $117.83 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of CellaVision AB for net asset value and shareholders' equity analysis.

CellaVision AB - Total Assets Trend (2000–2025)

This chart illustrates how CellaVision AB's total assets have evolved over time, based on quarterly financial data.

CellaVision AB - Asset Composition Analysis

Current Asset Composition (December 2025)

CellaVision AB's total assets of Skr1.09 Billion consist of 40.3% current assets and 59.7% non-current assets.

Asset Category	Amount (SEK)	% of Total Assets
Cash & Equivalents	Skr0.00	17.2%
Accounts Receivable	Skr141.07 Million	12.9%
Inventory	Skr111.81 Million	10.2%
Property, Plant & Equipment	Skr122.37 Million	11.2%
Intangible Assets	Skr408.20 Million	37.3%
Goodwill	Skr120.68 Million	11.0%

Asset Composition Trend (2000–2025)

This chart illustrates how CellaVision AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see CEVI market cap.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: CellaVision AB's current assets represent 40.3% of total assets in 2025, an increase from 0.0% in 2000.
Cash Position: Cash and equivalents constituted 17.2% of total assets in 2025, down from 71.5% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 48.0% of total assets, an increase from 0.0% in 2000.
Asset Diversification: The largest asset category is intangible assets at 37.3% of total assets.

CellaVision AB Competitors by Total Assets

Key competitors of CellaVision AB based on total assets are shown below.

Company	Country	Total Assets
Demant A/S CO:DEMANT	Denmark	Dkr39.07 Billion
Double Medical Technology Inc SHE:002901	China	CN¥4.55 Billion
Beijing Wandong Medical Technology Co Ltd SHG:600055	China	CN¥5.70 Billion
Sinocare Inc SHE:300298	China	CN¥6.25 Billion
MODULIGHT OY EO 1 F:78W	Germany	€49.14 Million
Diagnostic Medical Systems SA PA:ALDMS	France	€57.17 Million
Theradiag SA PA:ALTHE	France	€11.55 Million
Nova EYE Medical Ltd AU:EYE	Australia	AU$23.67 Million

CellaVision AB - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.98	3.72	2.87
Quick Ratio	2.97	2.56	2.14
Cash Ratio	0.00	0.00	0.00
Working Capital	Skr330.17 Million	Skr293.70 Million	Skr213.17 Million

CellaVision AB - Advanced Valuation Insights

This section examines the relationship between CellaVision AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	4.01
Latest Market Cap to Assets Ratio	0.28
Asset Growth Rate (YoY)	8.2%
Total Assets	Skr1.09 Billion
Market Capitalization	$311.10 Million USD

Valuation Analysis

Below Book Valuation: The market values CellaVision AB's assets below their book value (0.28x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: CellaVision AB's assets grew by 8.2% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for CellaVision AB (2000–2025)

The table below shows the annual total assets of CellaVision AB from 2000 to 2025.

Year	Total Assets	Change
2025-12-31	Skr1.09 Billion ≈ $117.83 Million	+8.20%
2024-12-31	Skr1.01 Billion ≈ $108.90 Million	+8.96%
2023-12-31	Skr928.71 Million ≈ $99.94 Million	+4.15%
2022-12-31	Skr891.75 Million ≈ $95.97 Million	+8.06%
2021-12-31	Skr825.21 Million ≈ $88.81 Million	+23.53%
2020-12-31	Skr668.02 Million ≈ $71.89 Million	+4.10%
2019-12-31	Skr641.71 Million ≈ $69.06 Million	+72.14%
2018-12-31	Skr372.78 Million ≈ $40.12 Million	+24.01%
2017-12-31	Skr300.60 Million ≈ $32.35 Million	+17.22%
2016-12-31	Skr256.44 Million ≈ $27.60 Million	+16.34%
2015-12-31	Skr220.43 Million ≈ $23.72 Million	+8.99%
2014-12-31	Skr202.25 Million ≈ $21.77 Million	+7.25%
2013-12-31	Skr188.57 Million ≈ $20.29 Million	+5.61%
2012-12-31	Skr178.56 Million ≈ $19.22 Million	-0.10%
2011-12-31	Skr178.73 Million ≈ $19.23 Million	+9.99%
2010-12-31	Skr162.50 Million ≈ $17.49 Million	+43.36%
2009-12-31	Skr113.35 Million ≈ $12.20 Million	+17.50%
2008-12-31	Skr96.47 Million ≈ $10.38 Million	+118.66%
2007-12-31	Skr44.12 Million ≈ $4.75 Million	+6.75%
2006-12-31	Skr41.33 Million ≈ $4.45 Million	-10.62%
2005-12-31	Skr46.24 Million ≈ $4.98 Million	+2.49%
2004-12-31	Skr45.12 Million ≈ $4.86 Million	+47.78%
2003-12-31	Skr30.53 Million ≈ $3.29 Million	-58.57%
2002-12-31	Skr73.69 Million ≈ $7.93 Million	-36.12%
2001-12-31	Skr115.35 Million ≈ $12.41 Million	+35.89%
2000-12-31	Skr84.89 Million ≈ $9.13 Million	--

About CellaVision AB

ST:CEVI Sweden Medical Devices

Market Cap

$311.10 Million

Skr2.89 Billion SEK

Market Cap Rank

#14799 Global

#231 in Sweden

Share Price

Skr121.20

Change (1 day)

-1.14%

52-Week Range

Skr120.20 - Skr200.00

All Time High

Skr478.48